e-learning
resources
Stockholm 2002
Monday 16.09.2002
Cardiovascular aspects of sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
L. S. Doherty, V. Swan, W. T. McNicholas (Elm Park, Ireland)
Source:
Annual Congress 2002 - Cardiovascular aspects of sleep apnoea
Session:
Cardiovascular aspects of sleep apnoea
Session type:
Thematic Poster Session
Number:
1857
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. S. Doherty, V. Swan, W. T. McNicholas (Elm Park, Ireland). Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP. Eur Respir J 2002; 20: Suppl. 38, 1857
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Long-term CPAP compliance in women with obstructive sleep apnoea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Predicting outcome of nasal surgery in patients with obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 246
Year: 2008
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
Short- and long-term prevalence of complex sleep apnoea in patients treated for obstructive sleep apnoea
Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation
Year: 2009
Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Nasal resistance and CPAP compliance in a large series of obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006
Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006
Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 410s
Year: 2006
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004
Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 103s
Year: 2002
Improving adherence to treatment in patients with obstructive sleep apnoea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
Long-term outcome of nCPAP therapy in sleep apnoea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010
Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients
Source: Eur Respir J 2008; 31: 223-225
Year: 2008
CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept